Table 3.
Peripheral blood immunoglobins and complements of patients with UC ( ± s, g/L).
Group | n | IgG | IgA | IgM | C3 | C4 | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
BT | AT | BT | AT | BT | AT | BT | AT | BT | AT | ||
Experiment group | 41 | 12.7 ± 2.8 | 12.3 ± 2.4 | 2.36 ± 0.84 | 2.26 ± 0.76 | 1.56 ± 0.73 | 1.43 ± 0.70 | 1.08 ± 0.34 | 1.03 ± 0.33 | 0.31 ± 0.12 | 0.30 ± 0.11 |
Control group | 41 | 13.2 ± 2.9 | 12.9 ± 2.8 | 2.48 ± 1.23 | 2.42 ± 1.01 | 1.51 ± 0.80 | 1.48 ± 0.72 | 1.06 ± 0.28 | 1.02 ± 0.27 | 0.27 ± 0.10 | 0.27 ± 0.11 |
t value | — | 0.794 | 1.042 | 0.516 | 0.811 | 0.296 | 0.319 | 0.291 | 0.311 | 1.640 | 1.235 |
P value | — | 0.430 | 0.299 | 0.633 | 0.419 | 0.765 | 0.756 | 0.77 | 0.742 | 0.106 | 0.226 |
BT stands for “before treatment”. AT stands for “two months after treatment”. The statistics using t-test.